| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |